RxDoctor Payments Data

Bobby le, PA

Physician Assistant · Hays, TXNPI 1063113843

Payments from drug & device makers

$916in general payments, 2019–2025

Across 45 payments — averaging $20.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$299
  • Boehringer Ingelheim$187
  • GSK$111
  • AstraZeneca$69
  • Dexcom, Inc.$60
  • Exact Sciences$55
  • plus $134 from 4 others

What the payments were for

  • Food & beverage$916100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$916 in reported general payments places this provider in the 60th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$85,649
Medicare patients
406
Services billed
1,327

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$15,210
EliquisApixaban16$14,136
OzempicSemaglutide11$12,924
MounjaroTirzepatide12$12,071
Duloxetine Hcl45$1,479
Wixela InhubFluticasone Propion/Salmeterol17$1,369
Gabapentin67$1,068
SynthroidLevothyroxine Sodium18$984
Levothyroxine Sodium86$879
Albuterol Sulfate HfaAlbuterol Sulfate33$879
Bupropion XlBupropion Hcl25$832
Lisinopril55$790
Olmesartan Medoxomil26$724
Ipratropium Bromide25$696
Rosuvastatin Calcium65$694

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$111$15,21023 claims
PfizerEliquis$23$14,13616 claims
Novo NordiskOzempic$299$12,92411 claims
Lilly USA, LLCMounjaro$51$12,07112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Hays

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →